Dr Corey Casper | Chief Scientific Officer
Infectious Disease Research Institute

Dr Corey Casper, Chief Scientific Officer, Infectious Disease Research Institute

Corey Casper is the Chief Medical Officer at the Infectious Disease Research Institute in Seattle, where is also serves as a Clinical Professor of Medicine and Adjunct Professor of Global Health at the University of Washington and an Affiliate Member at the Fred Hutchinson Cancer Research Center.
Dr. Casper’s research focuses on viruses associated with cancer,  infections in the immunocompromised host, and developing biomedical approaches to the prevention and treatment of infectious diseases that impact persons in low- and middle-income regions.
Dr. Casper received his medical degree from Cornell University, and completed a residency in Internal Medicine at the University of California – San Francisco and a fellowship in Infectious Disease at the University of Washington, where he also earned a Masters of Public Health. For 15 years he served on the faculty of the University of Washington and the Fred Hutchinson Cancer Research Center, where he rose to the rank of Full Professor. While at the Fred Hutch, Dr. Casper founded and directed the first Program in Global Oncology at a US National Cancer Institute-Designated Cancer Center. With a flagship collaboration between the Fred Hutch and the Uganda Cancer Institute, Dr. Casper helped to define the biology of infection-related cancers, developed approaches to the prevention and treatment of cancer in low-resource settings, and trained more than 300 individuals from sub-Saharan Africa in cancer and infectious disease care and research, increasing the number of full-time practicing oncologists in Uganda from 1 in 2004 to more than 15 today. He also designed and secured funding for the first collaborative comprehensive cancer center to be built in sub-Saharan Africa, a 10 million dollar, 28,000 square foot facility in Kampala capable of treating up to 20,000 patients a year and conducting state-of-the-art research and training. He conducted more than two dozen translational and clinical trials in Uganda with more than 12 million dollars in federal grant funding.
In Seattle, Dr. Casper treats patients at Seattle Cancer Care Alliance and the University of Washington Medical Center. He has authored nearly 100 peer reviewed publications, and has served on several national and international advisory boards, including helping to lead the NCI-funded AIDS Malignancy Consortium, the National Cancer Advisory Board subcommittee on Global Health, and Glaxo Smith Kline and Temptime corporations. He writes national care guidelines for infections in immunocompromised patients for the Centers for Disease Control and Prevention, U.S. Preventive Services Task Force and the National Comprehensive Cancer Network. He also serves as the Co-Director of the UW / Fred Hutch Center for AIDS Research.

back to speakers